Mental health is an underrepresented issue in dermatology even though numerous skin diseases are associated with mental health diseases, said Eva R. Parker, MD, associate professor of dermatology at Vanderbilt University Medical Center and president of the Nashville Dermatologic Society.
Mental health is an underrepresented issue in dermatology even though numerous skin diseases are associated with mental health diseases, said Eva R. Parker, MD, associate professor of dermatology at Vanderbilt University Medical Center and president of the Nashville Dermatologic Society.
In addition, climate change is having an important impact on and exacerbating both atopic dermatitis and mental health conditions. In recent research, Parker and her colleagues found climate change is exacerbating the environmental triggers of atopic dermatitis and amplifying comorbid mental health conditions, such as depression, anxiety, and trauma-related disorders.1
Transcript
You've written about the nexus of climate change, atopic dermatitis, and mental health. Can you explain why it's important to look at all 3 of them together?
I would say just in general, when you look at inflammatory skin diseases, they often have numerous comorbidities: cardiovascular disease, diabetes and metabolic syndrome, mental health issues, liver and kidney disease. That's not unique to atopic dermatitis. We see similar associations with psoriasis and hidradenitis suppurativa. But when we think about how climate change impacts other organ systems, as well as impacting the skin, it really is a double hit.
I chose to focus on mental health because I think it's an issue that is underrepresented in dermatology, numerous skin diseases have associated mental health diseases. And when one flares, the other may flare, and climate change has really important impacts on both atopic dermatitis, as well as exacerbating underlying mental health disease.
What can we attribute to the idea that when the skin condition flares, the mental health condition also flares?
Certainly, it can be the fact that if skin diseases flaring, that's something that is outward and obvious to other people. And so, it can be an issue of self-esteem. People can begin to feel alienated and isolated as a result of their skin disease. But in addition, there are often biochemical reasons as well. The same inflammatory cytokines that flare skin disease have also been implicated in the pathogenesis of certain mental health disorders.
Reference
Kam S, Hwang BJ, Parker ER. The impact of climate change on atopic dermatitis and mental health comorbidities: a review of the literature and examination of intersectionality. Int J Dermatol. Published online January 14, 2023. doi:10.1111/ijd.16557
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
November 20th 2024This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
November 20th 2024Professional guidelines say that when pulmonary arterial hypertension (PAH) is diagnosed, right heart catheterization should be performed, but a quarter of the time, it isn’t—so investigators set out to discover why.
Read More
OS Better With Belantamab Mafodotin Triplet vs Daratumumab in R/R MM
November 19th 2024The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R MM).
Read More